Macrocyclic lactones inhibit nasopharyngeal carcinoma cells proliferation through PAK1 inhibition and reduce in vivo tumor growth

Abstract

Macrocyclic lactones appear as promising molecules against NPC targeting PAK-1 with no detectable adverse effect.